These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18180797)

  • 1. Transplantation: it may take two to tango and to treat.
    Martin F
    Immunol Cell Biol; 2008 Feb; 86(2):107-8. PubMed ID: 18180797
    [No Abstract]   [Full Text] [Related]  

  • 2. B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates.
    Liu C; Noorchashm H; Sutter JA; Naji M; Prak EL; Boyer J; Green T; Rickels MR; Tomaszewski JE; Koeberlein B; Wang Z; Paessler ME; Velidedeoglu E; Rostami SY; Yu M; Barker CF; Naji A
    Nat Med; 2007 Nov; 13(11):1295-8. PubMed ID: 17965721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction therapy: why, when, and which agent?
    Krischock L; Marks SD
    Pediatr Transplant; 2010 May; 14(3):298-313. PubMed ID: 20345609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination treatment of low dose Anti-Thymocyte Globulin (ATG), Rituximab and high dose Sirolimus as induction agents in immune-conditioned recipients.
    Ravichandran P; Natrajan T; Jaganathan R
    Int Immunopharmacol; 2006 Dec; 6(13-14):1973-6. PubMed ID: 17161350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation.
    Campbell PM; Salam A; Ryan EA; Senior P; Paty BW; Bigam D; McCready T; Halpin A; Imes S; Al Saif F; Lakey JR; Shapiro AM
    Am J Transplant; 2007 May; 7(5):1242-8. PubMed ID: 17456201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of rapamycin on islet and skin xenograft survival.
    Bobbio SA; Porter JG; Monaco AP
    Transplant Proc; 1993 Aug; 25(4):2745-6. PubMed ID: 8356733
    [No Abstract]   [Full Text] [Related]  

  • 7. Rabbit antithymocyte globulin induction and sirolimus monotherapy supports prolonged islet allograft function in a nonhuman primate islet transplantation model.
    Hirshberg B; Preston EH; Xu H; Tal MG; Neeman Z; Bunnell D; Soleimanpour S; Hale DA; Kirk AD; Harlan DM
    Transplantation; 2003 Jul; 76(1):55-60. PubMed ID: 12865786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolongation of allograft survival with Ling Zhi-8, a new immunosuppressive drug.
    van der Hem LG; van der Vliet JA; Bocken CF; Kino K; Hoitsma AJ; Tax WJ
    Transplant Proc; 1994 Apr; 26(2):746. PubMed ID: 8171639
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of antipassenger lymphocyte globulin on functional graft survival of discordant xenoislet grafts from a large animal donor.
    Troppmann C; Papalois BE; Gruessner AC; Moon C; Matas AJ; Nakhleh RE; Gruessner RW
    Transplant Proc; 1996 Apr; 28(2):842-4. PubMed ID: 8623429
    [No Abstract]   [Full Text] [Related]  

  • 10. Substantial peripheral T-cell depletion before grafting is beneficial in islet transplantation.
    Brons IG; Davies HS; Watson CJ; Cobbold SP; Waldmann H; Calne RY
    Transplant Proc; 1995 Dec; 27(6):3181. PubMed ID: 8539899
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of monoclonal antibodies to T cells (OKT3) for treatment of acute cellular rejection after renal transplantation.
    Birkeland SA; Svendsen V; Rohr N; Hansen BL; Elbirk A; Foged N; Køhler F
    Transplant Proc; 1988 Jun; 20(3):451-4. PubMed ID: 3289183
    [No Abstract]   [Full Text] [Related]  

  • 12. Transplantation 1992: the year in review.
    Goodman ER; Hardy MA
    Clin Transpl; 1992; ():285-97. PubMed ID: 1306706
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to Gaber.
    Sollinger H; Neidlinger NA
    Transplant Proc; 2010 Jun; 42(5):1401. PubMed ID: 20620443
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of anti-T-lymphocyte monoclonal antibody (5G2) therapy for prolongation of canine islet allograft survival.
    Brendel MD; Schachner RS; Kong SS; Qian T; Alejandro R; Mintz DH
    Transplant Proc; 1994 Apr; 26(2):743-4. PubMed ID: 8171637
    [No Abstract]   [Full Text] [Related]  

  • 15. Current status of immunosuppressive agents for solid organ transplantation in children.
    Coelho T; Tredger M; Dhawan A
    Pediatr Transplant; 2012 Mar; 16(2):106-22. PubMed ID: 22360399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation.
    Pan H; Lu HM; Hu WM; Tian BL; Liu XB; Zhang ZD; Mai G
    Transplant Proc; 2007 Dec; 39(10):3452-4. PubMed ID: 18089405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of primary nonfunction of xenograft islets.
    Pittman K; Henretta J; McFadden T; Thomas J; Thomas FT
    Transplant Proc; 1994 Jun; 26(3):1141-2. PubMed ID: 8029862
    [No Abstract]   [Full Text] [Related]  

  • 18. Xenografting of pig islets in monkeys does not result in hyperacute rejection.
    Rijkelijkhuizen JK; Ossevoort M; Ringers J; van der Burg MP; Kuhn EM; Wubben J; Haanstra K; Bouwman E; Jonker M
    Transplant Proc; 2000 Aug; 32(5):1064. PubMed ID: 10936356
    [No Abstract]   [Full Text] [Related]  

  • 19. Production of marked prolongation of survival of canine islet xenografts in mice by antilymphocyte sera and L3T4 antibody.
    Kowalski L; Falqui L; Lacy PE; Scharp DW
    Transplantation; 1991 Dec; 52(6):1094-7. PubMed ID: 1750074
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of thymoglobulin induction therapy in the prevention of acute graft rejection episodes following liver transplantation.
    Tchervenkov J; Flemming C; Guttmann RD; des Gachons G
    Transplant Proc; 1997 Nov; 29(7A):13S-15S. PubMed ID: 9366919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.